| Literature DB >> 35332419 |
Mojgan Soleimanizadeh1, Mokhtar Jalali Javaran2, Abdolreza Bagheri3, Mahdi Behdani4.
Abstract
Targeting of vascular endothelial growth factor (VEGF) using AntiVEGF can be a promising approach for angiogenesis inhibition and cancer therapy. In this study, we direct AntiVEGF recombinant protein accumulation to cucurbit plant apoplast using a suitable signal (Pr1b) sequence. After assembling the target gene construct and cloning into the expression vector, we infected the plants with the resulting pZYMV-AntiVEGF viral vector. Transcription of the target gene was confirmed with RT-PCR assays. The apoplast-targeted AntiVEGF recombinant protein was detected in infected plants by Dot-blot, western blot, and ELISA analysis. AntiVEGF protein accumulation in the apoplast resulted in levels of 1.2% of TSP (Total Soluble Protein) that demonstrated a two-order increase compared to the cytoplasm-targeted protein. After purification of AntiVEGF protein using aqueous two-phase system (ATPS), purified protein was analyzed with MTT assay. Our results reveal that production of biologically active and correctly processed apoplast-targeted AntiVEGF recombinant protein is possible in plant apoplast. The low level of cytoplasm-targeted AntiVEGF recombinant protein might result from the degradation of improperly folded protein.Entities:
Keywords: Apoplast; Cancer; Molecular pharming; Recombinant protein; Vascular endothelial growth factor
Mesh:
Substances:
Year: 2022 PMID: 35332419 DOI: 10.1007/s12033-022-00483-3
Source DB: PubMed Journal: Mol Biotechnol ISSN: 1073-6085 Impact factor: 2.860